| Dr Ann T Barnes, PSYD RD | |
|
825 East Golf Road, Suite 1127 Barnes & Klatt Pc, Arlington Heights, IL 60005 | |
| (847) 981-9200 | |
| (847) 981-9322 |
| Full Name | Dr Ann T Barnes |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 28 Years |
| Location | 825 East Golf Road, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982758793 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | (Illinois) | Primary |
| 133V00000X | Dietitian, Registered | (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Barnes And Klatt Pc | 1052369865 | 3 |
News Archive
Linda Andersson at Malmo University in Sweden has studied the ability of dendritic cells to sample the surrounding environment. To understand how different materials are taken up and what happens within the cells can for example facilitate the development of new vaccines.
The Associated Press: "Tens of thousands of protesters fed up with government spending marched to the U.S. Capitol on Saturday, showing their disdain for the president's health care plan with slogans such as 'Obamacare makes me sick' and 'I'm not your ATM.'
We have been working very hard to have our Trillennium Medical Imaging System ready to go to market. As most are aware we have been waiting for the Duke Study to be published in the ADVANCES IN SKIN AND WOUND CARE PUBLICATION JOURNAL. While everything has been submitted to the publisher and there have been two rounds of questions and clarifications resubmitted, we are confident and excited that we will have the results published in August or September.
Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, announces that it has signed an agreement with miRagen Therapeutics, Inc., to assess the delivery potential of Silence's proprietary DBTC delivery system with miRagen's novel microRNA-based therapeutics.
› Verified 9 days ago
| Entity Name | Barnes & Klatt Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659425361 PECOS PAC ID: 1052369865 Enrollment ID: O20050108000090 |
News Archive
Linda Andersson at Malmo University in Sweden has studied the ability of dendritic cells to sample the surrounding environment. To understand how different materials are taken up and what happens within the cells can for example facilitate the development of new vaccines.
The Associated Press: "Tens of thousands of protesters fed up with government spending marched to the U.S. Capitol on Saturday, showing their disdain for the president's health care plan with slogans such as 'Obamacare makes me sick' and 'I'm not your ATM.'
We have been working very hard to have our Trillennium Medical Imaging System ready to go to market. As most are aware we have been waiting for the Duke Study to be published in the ADVANCES IN SKIN AND WOUND CARE PUBLICATION JOURNAL. While everything has been submitted to the publisher and there have been two rounds of questions and clarifications resubmitted, we are confident and excited that we will have the results published in August or September.
Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, announces that it has signed an agreement with miRagen Therapeutics, Inc., to assess the delivery potential of Silence's proprietary DBTC delivery system with miRagen's novel microRNA-based therapeutics.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ann T Barnes, PSYD RD 825 East Golf Road, Suite 1127 Barnes & Klatt Pc, Arlington Heights, IL 60005 Ph: (847) 981-9200 | Dr Ann T Barnes, PSYD RD 825 East Golf Road, Suite 1127 Barnes & Klatt Pc, Arlington Heights, IL 60005 Ph: (847) 981-9200 |
News Archive
Linda Andersson at Malmo University in Sweden has studied the ability of dendritic cells to sample the surrounding environment. To understand how different materials are taken up and what happens within the cells can for example facilitate the development of new vaccines.
The Associated Press: "Tens of thousands of protesters fed up with government spending marched to the U.S. Capitol on Saturday, showing their disdain for the president's health care plan with slogans such as 'Obamacare makes me sick' and 'I'm not your ATM.'
We have been working very hard to have our Trillennium Medical Imaging System ready to go to market. As most are aware we have been waiting for the Duke Study to be published in the ADVANCES IN SKIN AND WOUND CARE PUBLICATION JOURNAL. While everything has been submitted to the publisher and there have been two rounds of questions and clarifications resubmitted, we are confident and excited that we will have the results published in August or September.
Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, announces that it has signed an agreement with miRagen Therapeutics, Inc., to assess the delivery potential of Silence's proprietary DBTC delivery system with miRagen's novel microRNA-based therapeutics.
› Verified 9 days ago